Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Igor F Tsigelny

Showing results (81-90 of 86) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 86 results.
Bioorganic & Medicinal Chemistry Letters|October 8, 2014
Discovery of substituted 4-aminoquinazolines as selective Toll-like receptor 4 ligandsAfshin Nour, Tomoko Hayashi, Michael Chan, et al.
Oncotarget|October 31, 2015
Multiple spatially related pharmacophores define small molecule inhibitors of OLIG2 in glioblastomaIgor F Tsigelny, Rajesh Mukthavaram, Valentina L Kouznetsova, et al.
Journal of Medicinal Chemistry|May 10, 2013
Identification of substituted pyrimido[5,4-b]indoles as selective Toll-like receptor 4 ligandsMichael Chan, Tomoko Hayashi, Richard D Mathewson, et al.
Cancer Discovery|December 3, 2017
Genomic Landscape of Cell-Free DNA in Patients with Colorectal CancerJohn H Strickler, Jonathan M Loree, Leanne G Ahronian, et al.
Brain : a Journal of Neurology|September 29, 2016
A de novo compound targeting α-synuclein improves deficits in models of Parkinson's diseaseWolfgang Wrasidlo, Igor F Tsigelny, Diana L Price, et al.
Nature|August 28, 2024
Fibrin drives thromboinflammation and neuropathology in COVID-19Jae Kyu Ryu, Zhaoqi Yan, Mauricio Montano, et al.
Pageof 9

Showing results (81-90 of 86) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 86 results.
Bioorganic & Medicinal Chemistry Letters|October 8, 2014
Discovery of substituted 4-aminoquinazolines as selective Toll-like receptor 4 ligandsAfshin Nour, Tomoko Hayashi, Michael Chan, et al.
Oncotarget|October 31, 2015
Multiple spatially related pharmacophores define small molecule inhibitors of OLIG2 in glioblastomaIgor F Tsigelny, Rajesh Mukthavaram, Valentina L Kouznetsova, et al.
Journal of Medicinal Chemistry|May 10, 2013
Identification of substituted pyrimido[5,4-b]indoles as selective Toll-like receptor 4 ligandsMichael Chan, Tomoko Hayashi, Richard D Mathewson, et al.
Cancer Discovery|December 3, 2017
Genomic Landscape of Cell-Free DNA in Patients with Colorectal CancerJohn H Strickler, Jonathan M Loree, Leanne G Ahronian, et al.
Brain : a Journal of Neurology|September 29, 2016
A de novo compound targeting α-synuclein improves deficits in models of Parkinson's diseaseWolfgang Wrasidlo, Igor F Tsigelny, Diana L Price, et al.
Nature|August 28, 2024
Fibrin drives thromboinflammation and neuropathology in COVID-19Jae Kyu Ryu, Zhaoqi Yan, Mauricio Montano, et al.
Pageof 9